Jeffrey Redshaw, MD
Urology · Missoula, MTNPI 1134548597
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,870 of the $4,305 with a category attached, or 89.9%. It is spread thinly across 36 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,085, 2.3 times the $481 reported in 2019.
Across 163 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$658
- Dendreon Pharmaceuticals LLC$431
- Procept Biorobotics Corporation$409
- Boston Scientific$352
- Johnson & Johnson$298
- AbbVie$284
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,87090%
- Education$43510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 15 | $658 |
| Dendreon Pharmaceuticals LLC | 14 | $431 |
| Procept Biorobotics Corporation | 5 | $409 |
| Boston Scientific | 22 | $352 |
| Johnson & Johnson | 13 | $298 |
| AbbVie(2 entities) | 17 | $284 |
| Dornier Medtech America, Inc | 2 | $251 |
| Pfizer | 8 | $147 |
| Laborie Medical Technologies Corp. | 4 | $143 |
| Rochester Medical Corporation | 7 | $134 |
| Merck | 5 | $119 |
| Endo Pharmaceuticals Inc. | 7 | $116 |
| Intuitive Surgical | 2 | $111 |
| Axonics, Inc. | 3 | $110 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| Amgen | 3 | $65 |
| Bayer | 3 | $58 |
| Teleflex LLC | 2 | $56 |
| Ambu Inc. | 3 | $53 |
| Sun Pharmaceutical Industries Inc. | 2 | $52 |
| Immunitybio, Inc. | 3 | $50 |
| 180 Medical, Inc. | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $42 |
| Endo USA, Inc. | 2 | $35 |
| Myovant Sciences Inc. | 2 | $33 |
| Palette Life Sciences, Inc. | 1 | $22 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Telix Pharmaceuticals | 1 | $16 |
| Accord Healthcare, Inc. | 1 | $15 |
| Cook Medical LLC | 1 | $15 |
| Profound Medical Corp. | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
| Photocure Inc | 1 | $13 |
| Coloplast | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dornier MedTech$251
- AquaBeam Robotic System$227
- PROVENGE$150
How this compares
$4,305 in reported general payments places this provider in the 80th percentile of 45 urology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 97 | $243,664 |
| ErleadaApalutamide | 13 | $193,473 |
| XtandiEnzalutamide | 13 | $186,746 |
| Abiraterone Acetate | 51 | $55,102 |
| MyrbetriqMirabegron | 20 | $21,236 |
| GemtesaVibegron | 22 | $20,200 |
| Tamsulosin Hcl | 185 | $2,490 |
| Finasteride | 82 | $1,014 |
| Prednisone | 29 | $277 |
| Tramadol Hcl | 90 | $122 |
| Levofloxacin | 53 | $98 |
| Cefpodoxime Proxetil | 14 | $77 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $78 | $263,863119 claims |
| Astellas Pharma US IncXtandi, Myrbetriq | $658 | $207,98333 claims |
| Johnson & JohnsonErleada | $298 | $193,47313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 45 urology providers in Montana.
Other urology in Missoula
- Garrick SimmonsMissoula$16K
- Karl WestenfelderMissoula$4K
- Matthew MundingMissoula$3K
- Christopher WicherMissoula$2K
- Jason ReynoldsMissoula$2K
- Kevin KronnerMissoula$2K
- Christopher FukudaGreat Falls$19K
- Morris JessopGreat Falls$12K
- Jason SkenazyBozeman$12K
- Amy McKerrowKalispell$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.